This gene-based therapeutics stock could nearly triple, analysts say
Three firms initiated coverage of the the gene-based therapeutics company.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cnbc.com — the content belongs to CNBC.